WO1994024291A3 - Compositions of antigen containing recombinant salmonella, their use in anti-malarial vaccines and method for their preparation - Google Patents
Compositions of antigen containing recombinant salmonella, their use in anti-malarial vaccines and method for their preparation Download PDFInfo
- Publication number
- WO1994024291A3 WO1994024291A3 PCT/US1994/004168 US9404168W WO9424291A3 WO 1994024291 A3 WO1994024291 A3 WO 1994024291A3 US 9404168 W US9404168 W US 9404168W WO 9424291 A3 WO9424291 A3 WO 9424291A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- preparation
- containing recombinant
- antigen containing
- recombinant salmonella
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000607142 Salmonella Species 0.000 title 1
- 230000000078 anti-malarial effect Effects 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 239000003430 antimalarial agent Substances 0.000 title 1
- 230000000890 antigenic effect Effects 0.000 abstract 2
- 230000002163 immunogen Effects 0.000 abstract 2
- 101710132601 Capsid protein Proteins 0.000 abstract 1
- 241000700721 Hepatitis B virus Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU67055/94A AU6705594A (en) | 1993-04-15 | 1994-04-15 | Compositions of antigen containing recombinant salmonella, their use in anti-malarial vaccines and method for their preparation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4816693A | 1993-04-15 | 1993-04-15 | |
US08/048,166 | 1993-04-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1994024291A2 WO1994024291A2 (en) | 1994-10-27 |
WO1994024291A3 true WO1994024291A3 (en) | 1994-12-08 |
Family
ID=21953082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1994/004168 WO1994024291A2 (en) | 1993-04-15 | 1994-04-15 | Compositions of antigen containing recombinant salmonella, their use in anti-malarial vaccines and method for their preparation |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6705594A (en) |
WO (1) | WO1994024291A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9580718B2 (en) | 2013-06-17 | 2017-02-28 | Arizona Board Of Regents On Behalf Of Arizona State University | Attenuated live bacteria with increased acid resistance and methods of use thereof |
US9598697B2 (en) | 2010-05-28 | 2017-03-21 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant bacterium to decrease tumor growth |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6274792B1 (en) | 1995-06-20 | 2001-08-14 | Ming-Tang Chang | Plants and processes for obtaining them |
US5922583A (en) * | 1995-10-17 | 1999-07-13 | Biostar Inc. | Methods for production of recombinant plasmids |
US6024961A (en) | 1997-11-14 | 2000-02-15 | Washington University | Recombinant avirulent immunogenic S typhi having rpos positive phenotype |
EP2150616A4 (en) | 2007-05-10 | 2011-07-27 | Univ Arizona | Regulated synthesis of antigen and/or regulated attentuation to enhance vaccine immunogenics and/or safety |
US8465755B2 (en) | 2007-10-05 | 2013-06-18 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant bacterium capable of eliciting an immune response against enteric pathogens |
WO2010045620A1 (en) | 2008-10-17 | 2010-04-22 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae |
US9163219B2 (en) | 2009-04-14 | 2015-10-20 | Arizona Board Of Regents On Behalf Of Arizona State University | Single expression vector for generation of a virus with a segmented genome |
GB2483595B (en) | 2009-05-22 | 2017-03-29 | The Arizona Board Of Regents For And On Behalf Of Arizona State Univ | Recombinant bacterium and methods of antigen and nucleic acid delivery |
US9045742B2 (en) | 2009-05-29 | 2015-06-02 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant Edwardsiella bacterium |
US9062297B2 (en) | 2010-01-13 | 2015-06-23 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Yersinia pestis vaccine |
WO2011091291A1 (en) | 2010-01-22 | 2011-07-28 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | BACTERIUM COMPRISING A REGULATED rfaH NUCLEIC ACID |
US9303264B2 (en) | 2012-05-18 | 2016-04-05 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Photosynthetic microorganisms expressing thermostable lipase |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988010300A1 (en) * | 1987-06-22 | 1988-12-29 | Medico Labs Ag | Heterologous viral peptide particle immunogens |
WO1989002924A1 (en) * | 1987-10-02 | 1989-04-06 | Praxis Biologics, Inc. | Vaccines for malaria |
-
1994
- 1994-04-15 WO PCT/US1994/004168 patent/WO1994024291A2/en active Application Filing
- 1994-04-15 AU AU67055/94A patent/AU6705594A/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988010300A1 (en) * | 1987-06-22 | 1988-12-29 | Medico Labs Ag | Heterologous viral peptide particle immunogens |
WO1989002924A1 (en) * | 1987-10-02 | 1989-04-06 | Praxis Biologics, Inc. | Vaccines for malaria |
Non-Patent Citations (5)
Title |
---|
B.E. CLARKE ET AL.: "Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein", NATURE, vol. 330, no. 6146, 26 November 1987 (1987-11-26), LONDON GB, pages 381 - 384 * |
FLORIAN SCHÖDEL ET AL.: "Avirulent Salmonella typhimurium and S. typhi expressing hybrid Hepatitis B virus core/pre-S genes for oral vaccination", ABSTRACTS OF THE GENERAL MEETING OF THE AMERICAN SOCIETY FOR MICROBIOLOGY, May 1992 (1992-05-01), WASHINGTON US, pages 158 * |
FLORIAN SCHÖDEL ET AL.: "Hepatitis B virus nucleocapsid/pre-S2 fusion proteins expressed in attenuated Salmonella for oral vaccination", JOURNAL OF IMMUNOLOGY., vol. 145, no. 12, 15 December 1990 (1990-12-15), BALTIMORE US, pages 4317 - 4321 * |
JOURNAL OF CELLULAR BIOCHEMISTRY Supplement 18C, 1994, page 232 PATRICIA LONDONO ET AL.:' Use of a double Salmonella mutant to stably express HPV16 * |
KOJI NAKAYAMA ET AL.: "Construction of an asd+ expression-cloning vector: stable maintenance and a high level expression of cloned genes in a Salmonella vaccine strain", BIOTECHNOLOGY, vol. 6, no. 6, June 1988 (1988-06-01), NEW YORK US, pages 693 - 697 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9598697B2 (en) | 2010-05-28 | 2017-03-21 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant bacterium to decrease tumor growth |
US9580718B2 (en) | 2013-06-17 | 2017-02-28 | Arizona Board Of Regents On Behalf Of Arizona State University | Attenuated live bacteria with increased acid resistance and methods of use thereof |
Also Published As
Publication number | Publication date |
---|---|
AU6705594A (en) | 1994-11-08 |
WO1994024291A2 (en) | 1994-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1994024291A3 (en) | Compositions of antigen containing recombinant salmonella, their use in anti-malarial vaccines and method for their preparation | |
CA2102918A1 (en) | Genetic vaccine for immunodeficiency viruses | |
WO1997001640A3 (en) | Vaccines against hepatitis c | |
WO1999048525A8 (en) | Hib/dtpa vaccine composition and methods of preparation | |
WO1993001210A3 (en) | Hcv peptide-antigens and a method of testing for the hepatitis c virus (hcv) | |
FI851859L (en) | ANTIGEN PREPARATORS AND CHARGING PRODUCTS FOR PREPARATION. | |
EP0330359A3 (en) | Composition useful in the diagnosis and treating of hiv-1 infection | |
EP1170016A3 (en) | Urease-based vaccine against helicobacter infection | |
WO2000000616A3 (en) | Marburg virus vaccines | |
EP0634937A1 (en) | Vaccines containing non-ionic surfactant vesicles. | |
DE3176404D1 (en) | Vaccine against viral hepatitis b, method and transformed eucaryotic cells for the preparation of this vaccine | |
AU2497292A (en) | Flavivirus envelope proteins with increased immunogenicity for use in immunization against virus infection | |
AU6979387A (en) | Fusion protein comprising influenza virus haemagglutinin and antigenic epitope | |
EP0232798A3 (en) | Pseudorabies virus mutants, vaccines containing same, methods for the production of same and methods for the use of same | |
AU580059B2 (en) | Vaccine against rabies and preparation process thereof | |
EP0134242A4 (en) | Protective peptide antigen. | |
AU2403188A (en) | Infectious bovine rhinotracheitis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same | |
DE3160264D1 (en) | Process for isolating viral glycoproteic antigens, and its use in the preparation of vaccines | |
NZ221227A (en) | Hiv envelope proteins, antigenic fragments vaccines; and diagnostic methods | |
AU1459792A (en) | Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods | |
EP0030063A3 (en) | Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines, process for preventing infectious bronchitis and infectious-bronchitis virus strains | |
NZ239948A (en) | Hiv gp160 modified at positions 502 and 510, vaccines and recombinant methods for producing modified gp160 | |
NZ213303A (en) | Plasmodium protein, dna sequence and vaccine | |
AU7547987A (en) | Method of preparation and use for feline leukemia virus antigens | |
CA2133108A1 (en) | Pasteurella haemolytica type a-1 bacterin-toxoid vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU BB BG BR BY CA CZ FI HU JP KP KR KZ LK LU MG MN MW NO NZ PL RO RU SD SK UA VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU BB BG BR BY CA CZ FI HU JP KP KR KZ LK LU MG MN MW NO NZ PL RO RU SD SK UA VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase |